BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11212254)

  • 1. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells.
    Tanno S; Tanno S; Mitsuuchi Y; Altomare DA; Xiao GH; Testa JR
    Cancer Res; 2001 Jan; 61(2):589-93. PubMed ID: 11212254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
    Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
    Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness.
    Duxbury MS; Ito H; Benoit E; Zinner MJ; Ashley SW; Whang EE
    Oncogene; 2004 Jul; 23(34):5834-42. PubMed ID: 15208677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
    Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells.
    Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H
    J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling.
    Zhang D; Brodt P
    Oncogene; 2003 Feb; 22(7):974-82. PubMed ID: 12592384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathway.
    Sumitomo M; Milowsky MI; Shen R; Navarro D; Dai J; Asano T; Hayakawa M; Nanus DM
    Cancer Res; 2001 Apr; 61(8):3294-8. PubMed ID: 11309283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells.
    Asano T; Yao Y; Zhu J; Li D; Abbruzzese JL; Reddy SA
    Oncogene; 2004 Nov; 23(53):8571-80. PubMed ID: 15467756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.
    Lu Y; Yu Q; Liu JH; Zhang J; Wang H; Koul D; McMurray JS; Fang X; Yung WK; Siminovitch KA; Mills GB
    J Biol Chem; 2003 Oct; 278(41):40057-66. PubMed ID: 12869565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells.
    Xu Z; Zhang Y; Jiang J; Yang Y; Shi R; Hao B; Zhang Z; Huang Z; Kim JW; Zhang G
    BMC Cancer; 2010 Apr; 10():161. PubMed ID: 20423485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells.
    Wan X; Helman LJ
    Oncogene; 2003 Nov; 22(50):8205-11. PubMed ID: 14603261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic downregulation of pregnancy-associated plasma protein-A (PAPP-A) by bikunin reduces IGF-I-dependent Akt and ERK1/2 activation and subsequently reduces ovarian cancer cell growth, invasion and metastasis.
    Tanaka Y; Kobayashi H; Suzuki M; Hirashima Y; Kanayama N; Terao T
    Int J Cancer; 2004 Apr; 109(3):336-47. PubMed ID: 14961570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of PTEN expression leading to high Akt activation in human multiple myelomas.
    Hyun T; Yam A; Pece S; Xie X; Zhang J; Miki T; Gutkind JS; Li W
    Blood; 2000 Nov; 96(10):3560-8. PubMed ID: 11071655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
    Mur C; Arribas M; Benito M; Valverde AM
    Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the Csk homologous kinase facilitates phosphorylation of Akt/PKB in MCF-7 cells.
    Zagozdzon R; Bougeret C; Fu Y; Avraham HK
    Int J Oncol; 2002 Dec; 21(6):1347-52. PubMed ID: 12429987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A HIF-1alpha-dependent autocrine feedback loop promotes survival of serum-deprived prostate cancer cells.
    Thomas R; Kim MH
    Prostate; 2009 Feb; 69(3):263-75. PubMed ID: 19016246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and activity of SRC regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis.
    Trevino JG; Summy JM; Gray MJ; Nilsson MB; Lesslie DP; Baker CH; Gallick GE
    Cancer Res; 2005 Aug; 65(16):7214-22. PubMed ID: 16103072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic blockade of the insulin-like growth factor-I receptor: a promising strategy for human pancreatic cancer.
    Min Y; Adachi Y; Yamamoto H; Ito H; Itoh F; Lee CT; Nadaf S; Carbone DP; Imai K
    Cancer Res; 2003 Oct; 63(19):6432-41. PubMed ID: 14559833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.